Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al
| Duchesnay Inc. |
| Teva Pharmaceuticals USA, Inc., Actavis Laboratories FL, Inc. and Teva Pharmaceutical Industries Ltd. |
| 1:2018cv01895 |
| November 29, 2018 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 23, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorneys Cora R. Holt and Danielle A. Duszczyszyn for Duchesnay Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) |
Filing 16
Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 2/27/2019, at 2:00 PM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 1/14/2019. (nms)
|
| Filing 15 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceuticals USA, Inc., Other Affiliate Teva Pharmaceutical Industries Ltd. for Actavis Laboratories FL, Inc. filed by Actavis Laboratories FL, Inc.. (Keller, Karen) |
| Filing 14 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Filing 13 ANSWER to #1 Complaint, and COUNTERCLAIMS against Duchesnay Inc., by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc..(Keller, Karen) Modified on 1/9/2019 (nms). |
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Jay P. Lefkowitz - filed by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
|
SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney Jay P. Lefkowitz, filed by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 1/7/2019. (nms)
|
|
SO ORDERED, re #10 MOTION for Pro Hac Vice Appearance of Attorney Barbara R. Rudolph, Danielle A. Duszczyszyn, and Cora R. Holt, filed by Duchesnay Inc.. Signed by Judge Richard G. Andrews on 12/19/2018. (nms)
|
|
SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney Jeanna Wacker, Jessica Lam, and Ashley L. Ross, filed by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 12/19/2018. (nms)
|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Jeanna Wacker, Jessica Lam, and Ashley L. Ross - filed by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Barbara R. Rudolph, Danielle A. Duszczyszyn, and Cora R. Holt - filed by Duchesnay Inc.. (Attachments: #1 Certifications)(Silver, Daniel) Modified on 12/19/2018 (nms). |
|
Filing 9
SO ORDERED Granting #8 Stipulation and Order Dismissing Without Prejudice Defendant Teva Pharmaceutical Industries Ltd. (*Party Teva Pharmaceutical Industries Ltd. terminated). Signed by Judge Richard G. Andrews on 12/13/2018. (nms)
|
|
Filing 8
STIPULATION and Order Dismissing Without Prejudice of [Teva Pharmaceutical Industries Ltd., by Teva Pharmaceutical Industries Ltd.. (Hoeschen, Nathan) Modified on 12/13/2018 (nms).
|
| Filing 7 WAIVER OF SERVICE returned executed by Duchesnay Inc.: For Actavis Laboratories FL, Inc. waiver sent on 12/12/2018, answer due 2/11/2019. (Silver, Daniel) |
| Filing 6 WAIVER OF SERVICE returned executed by Duchesnay Inc.: For Teva Pharmaceuticals USA, Inc. waiver sent on 12/12/2018, answer due 2/11/2019. (Silver, Daniel) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| No Summons Issued. (ceg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Duchesnay Inc. (ceg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,089,489; 9,375,404; 9,526,703; 9,937,132. (ceg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/16/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 4/16/2021. (ceg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Actavis Laboratories FL, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2514277.) - filed by Duchesnay Inc. (Attachments: #1 Exhibits A-D, #2 Civil Cover Sheet)(ceg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
